Pengenalan
Halaman ini menyediakan analisis menyeluruh tentang sejarah dagangan orang dalam yang diketahui Ernest Mario. Orang dalam ialah pegawai, pengarah atau pelabur penting dalam syarikat. Adalah haram bagi orang dalam untuk membuat perdagangan dalam syarikat mereka berdasarkan maklumat khusus bukan awam. Ini tidak bermakna haram bagi mereka untuk membuat sebarang perdagangan dalam syarikat mereka sendiri. Tetapi mereka mesti melaporkan semua perdagangan kepada SEC melalui Borang 4. Walaupun terdapat sekatan ini, penyelidikan akademik menunjukkan bahawa orang dalam - secara amnya - cenderung untuk mengatasi prestasi pasaran dalam syarikat mereka sendiri.
Purata Keuntungan Perdagangan
Purata keuntungan perdagangan ialah purata pulangan semua pembelian pasaran terbuka yang dibuat oleh orang dalam dalam tempoh tiga tahun terakhir. Untuk mengira ini, kami memeriksa setiap pembelian pasaran terbuka yang tidak dirancang oleh orang dalam, tidak termasuk semua dagangan yang ditandakan sebagai sebahagian daripada pelan dagangan 10b5-1. Kami kemudian mengira prestasi purata dagangan tersebut sepanjang 3, 6 dan 12 bulan, dengan purata setiap tempoh tersebut untuk menjana metrik prestasi akhir bagi setiap dagangan. Akhir sekali, kami puratakan semua metrik prestasi untuk mengira metrik prestasi untuk orang dalam. Senarai ini hanya termasuk orang dalam yang telah membuat sekurang-kurangnya tiga dagangan dalam dua tahun lepas.
Jika keuntungan berdagang orang dalam ini ialah "N/A", maka orang dalam sama ada tidak membuat sebarang pembelian pasaran terbuka dalam tempoh tiga tahun terakhir, atau dagangan yang mereka buat adalah terlalu baru untuk mengira metrik prestasi yang boleh dipercayai.
Kekerapan Kemas Kini: Harian
Syarikat dengan Kedudukan Orang Dalam yang Dilaporkan
Pemfailan SEC menunjukkan Ernest Mario telah melaporkan pegangan atau perdagangan dalam syarikat berikut:
Sekuriti | Tajuk | Pegangan Terkini Dilaporkan |
---|---|---|
US:SLNO / Soleno Therapeutics, Inc. | Director | 193,066 |
US:EYEN / Eyenovia, Inc. | Director | 9,653 |
Director | 49,000 | |
US:CELG / Celgene Corp. | Director | 0 |
US:TNXP / Tonix Pharmaceuticals Holding Corp. | Director | 50,000 |
US:CMRX / Chimerix, Inc. | Director | 108,167 |
US:BSX / Boston Scientific Corporation | Director | 86,032 |
US:XNPT / XenoPort, Inc. | Director | 0 |
US:928551AA8 / VIVUS, Inc. Bond | Director | 81,125 |
US:MAXY / Maxygen Inc | Director | 62,964 |
Bagaimana Mentafsir Carta
Carta berikut menunjukkan prestasi saham sekuriti selepas setiap dagangan pasaran terbuka dan tidak dirancang yang dibuat oleh Ernest Mario. Perdagangan tidak dirancang ialah dagangan yang tidak dibuat sebagai sebahagian daripada pelan dagangan 10b5-1. Prestasi saham dicatatkan sebagai perubahan peratus kumulatif dalam harga saham. Sebagai contoh, jika perdagangan orang dalam dibuat pada 1 Januari 2019, carta akan menunjukkan perubahan peratusan harian sekuriti kepada hari ini. Jika harga saham naik dari $10 kepada $15 pada masa ini, perubahan peratus terkumpul dalam harga saham ialah 50%. Perubahan dalam harga daripada $10 kepada $20 ialah 100% dan perubahan dalam harga $10 hingga $5 ialah -50%.
Secara dasarnya, kami cuba untuk menentukan sejauh mana dagangan orang dalam berkait rapat dengan pulangan berlebihan (positif atau negatif) dalam harga saham untuk melihat sama ada orang dalam menetapkan masa dagangan mereka untuk mendapat keuntungan daripada maklumat orang dalam. Pertimbangkan situasi di mana orang dalam melakukan perkara ini. Dalam keadaan ini, kami menjangkakan sama ada (a) pulangan positif selepas pembelian, atau (b) pulangan negatif selepas jualan. Dalam kes (a), carta PEMBELIAN akan menunjukkan satu siri keluk condong ke atas, menunjukkan pulangan positif selepas setiap transaksi pembelian. Dalam kes (b), carta JUALAN akan menunjukkan satu siri keluk condong ke bawah, menunjukkan pulangan negatif selepas setiap transaksi jualan.
Walau bagaimanapun, ini sahaja tidak cukup untuk membuat kesimpulan. Jika, sebagai contoh, harga saham syarikat berada dalam pendakian bukan disebabkan kitaran selama bertahun-tahun, maka kami menjangkakan semua plot selepas pembelian akan condong ke atas. Begitu juga, kemerosotan bukan disebabkan kitaran selama bertahun-tahun akan mengakibatkan plot pasca perdagangan condong ke bawah. Kedua-dua carta ini tidak akan mencadangkan aktiviti perdagangan orang dalam.
Penunjuk terkuat ialah keadaan di mana harga saham adalah sangat kitaran, dan terdapat kedua-dua isyarat positif dalam carta PEMBELIAN dan plot negatif pada carta JUALAN. Situasi ini akan sangat menunjukkan orang dalam yang menentukan masa perdagangan untuk kelebihan kewangan mereka.
Pembelian Orang Dalam HYPD / Hyperion DeFi, Inc. - Analisis Keuntungan Jangka Pendek
Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam HYPD / Hyperion DeFi, Inc.. Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .
Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.
Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.
Jualan Orang Dalam HYPD / Hyperion DeFi, Inc. - Analisis Kerugian Jangka Pendek
Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam HYPD / Hyperion DeFi, Inc.. Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .
Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.
Tarikh Dagangan | Simbol Saham | Orang dalam | Saham Dilaporkan |
Harga Dilaporkan |
Saham Dilaraskan |
Harga Dilaraskan |
Asas Kos | Hari ke Min |
Harga pada Min |
Kerugian Maks Dielakkan ($) |
Kerugian Maks Dielakkan (%) |
---|---|---|---|---|---|---|---|
Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini |
Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.
Pembelian Orang Dalam SLNO / Soleno Therapeutics, Inc. - Analisis Keuntungan Jangka Pendek
Dalam bahagian ini, kami menganalisis keuntungan setiap pembelian orang dalam pasaran terbuka yang tidak dirancang yang dibuat dalam HYPD / Hyperion DeFi, Inc.. Analisis ini membantu untuk memahami sama ada orang dalam secara konsisten menjana pulangan tidak normal dan patut diikuti. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah bersifat teori .
Jadual berikut menunjukkan pembelian pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.
Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.
Jualan Orang Dalam SLNO / Soleno Therapeutics, Inc. - Analisis Kerugian Jangka Pendek
Dalam bahagian ini, kami menganalisis pengelakan kerugian jangka pendek bagi setiap jualan dalaman pasaran terbuka yang tidak dirancang yang dibuat dalam HYPD / Hyperion DeFi, Inc.. Corak pengelakan kerugian yang konsisten mungkin mencadangkan bahawa urus niaga jualan masa hadapan mungkin meramalkan penurunan harga. Analisis ini adalah untuk satu tahun selepas setiap perdagangan, dan hasilnya adalah teori .
Jadual berikut menunjukkan jualan pasaran terbuka terkini yang bukan sebahagian daripada pelan dagangan automatik.
Tarikh Dagangan | Simbol Saham | Orang dalam | Saham Dilaporkan |
Harga Dilaporkan |
Saham Dilaraskan |
Harga Dilaraskan |
Asas Kos | Hari ke Min |
Harga pada Min |
Kerugian Maks Dielakkan ($) |
Kerugian Maks Dielakkan (%) |
---|---|---|---|---|---|---|---|
Tiada dagangan pasaran terbuka tidak dirancang yang tidak diketahui untuk gabungan orang dalam dan sekuriti ini |
Harga Larasan ialah harga larasan berpecah. Saham Larasan ialah saham terlaras berpecah.
Sejarah Dagangan Orang Dalam
Jadual ini menunjukkan senarai lengkap dagangan orang dalam yang dibuat oleh Ernest Mario seperti yang didedahkan kepada Suruhanjaya Bursa Sekuriti (SEC).
Tarikh Fail | Tarikh Tran | Borang | Simbol Saham | Sekuriti | Kod | Saham | Baki Saham | Peratus Ubah |
Saham harga |
Tran Nilai |
Baki Nilai |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-06-10 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 6,500 | 193,066 | 3.48 | ||||
2024-05-23 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
X - Other | 62,000 | 186,566 | 49.77 | 4.50 | 279,000 | 839,547 | |
2024-01-10 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
G - Gift | -3,523 | 124,566 | -2.75 | ||||
2023-12-04 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
G - Gift | -8,700 | 128,089 | -6.36 | ||||
2022-04-04 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Warrant (right to buy) |
P - Purchase | 930,000 | 930,000 | |||||
2022-04-04 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Warrant (right to buy) |
P - Purchase | 930,000 | 930,000 | |||||
2022-04-04 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 930,000 | 930,000 | |||||
2022-04-04 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 930,000 | 930,000 | |||||
2022-02-02 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 56,338 | 1,433,135 | 4.09 | 0.36 | 20,000 | 508,763 | |
2021-11-22 |
|
4 | EYEN |
EYENOVIA, INC.
Stock Option (right to buy) |
A - Award | 9,653 | 9,653 | |||||
2021-11-22 |
|
4 | EYEN |
EYENOVIA, INC.
Common Stock, par value $.0001 |
A - Award | 6,963 | 382,706 | 1.85 | ||||
2021-11-02 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 26,888 | 1,376,797 | 1.99 | ||||
2021-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 21,978 | 1,349,909 | 1.66 | 0.91 | 20,000 | 1,228,417 | |
2021-06-04 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Employee stock option (right to buy) |
A - Award | 31,862 | 31,862 | |||||
2021-05-04 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 16,529 | 1,176,416 | 1.43 | 1.21 | 20,000 | 1,423,463 | |
2021-02-02 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 8,928 | 1,157,804 | 0.78 | ||||
2021-01-22 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (right to buy) |
A - Award | 49,000 | 49,000 | |||||
2021-01-19 |
|
4 | EYEN |
EYENOVIA, INC.
Class A Warrant |
X - Other | -41,216 | 0 | -100.00 | ||||
2021-01-19 |
|
4 | EYEN |
EYENOVIA, INC.
Common Stock, par value $.0001 |
X - Other | 41,216 | 375,743 | 12.32 | 2.27 | 93,560 | 852,937 | |
2021-01-12 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Employee stock option (right to buy) |
A - Award | 40,000 | 40,000 | |||||
2020-11-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 10,057 | 1,148,876 | 0.88 | 1.74 | 17,499 | 1,999,044 | |
2020-09-15 |
|
4 | EYEN |
EYENOVIA, INC.
Stock Option (right to buy) |
A - Award | 9,820 | 9,820 | |||||
2020-09-15 |
|
4 | EYEN |
EYENOVIA, INC.
Common Stock, par value $.0001 |
A - Award | 7,288 | 334,527 | 2.23 | ||||
2020-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 10,174 | 10,174 | 1.72 | 17,499 | 17,499 | ||
2020-05-20 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Employee stock option (right to buy) |
A - Award | 9,530 | 9,530 | |||||
2020-05-04 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 5,738 | 5,738 | 3.05 | 17,501 | 17,501 | ||
2020-03-26 |
|
4 | EYEN |
EYENOVIA, INC.
Class B Warrant |
P - Purchase | 61,823 | 61,823 | |||||
2020-03-26 |
|
4 | EYEN |
EYENOVIA, INC.
Class A Warrant |
P - Purchase | 41,216 | 41,216 | |||||
2020-03-26 |
|
4 | EYEN |
EYENOVIA, INC.
Common Stock, par value $.0001 |
P - Purchase | 82,431 | 327,239 | 33.67 | 2.27 | 187,118 | 742,833 | |
2020-01-24 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 10,448 | 10,448 | 3.35 | 35,001 | 35,001 | ||
2020-01-22 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (right to buy) |
A - Award | 49,000 | 49,000 | |||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
D - Sale to Issuer | -4,756 | 0 | -100.00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
D - Sale to Issuer | -970 | 0 | -100.00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
D - Sale to Issuer | -300 | 0 | -100.00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -13,266 | 0 | -100.00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -10,500 | 0 | -100.00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -11,000 | 0 | -100.00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -10,000 | 0 | -100.00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -20,700 | 0 | -100.00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
D - Sale to Issuer | -4,908 | 0 | -100.00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
D - Sale to Issuer | -62,884 | 0 | -100.00 | ||||
2019-08-20 |
|
4 | EYEN |
EYENOVIA, INC.
Stock Option (right to buy) |
A - Award | 9,057 | 9,057 | |||||
2019-08-20 |
|
4 | EYEN |
EYENOVIA, INC.
Common Stock, par value $.0001 |
A - Award | 8,038 | 280,779 | 2.95 | ||||
2019-07-15 |
|
4 | EYEN |
EYENOVIA, INC.
Common Stock, par value $.0001 |
P - Purchase | 35,971 | 272,741 | 15.19 | 2.78 | 99,999 | 758,220 | |
2019-06-17 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -375 | 0 | -100.00 | ||||
2019-06-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 375 | 62,884 | 0.60 | ||||
2019-06-17 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -300 | 300 | -50.00 | ||||
2019-06-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 300 | 62,509 | 0.48 | ||||
2019-06-17 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -484 | 970 | -33.29 | ||||
2019-06-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 484 | 62,209 | 0.78 | ||||
2019-06-12 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Employee stock option (right to buy) |
A - Award | 13,000 | 13,000 | |||||
2019-06-05 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 4,756 | 4,756 | |||||
2019-05-21 |
|
4 | EYEN |
EYENOVIA, INC.
Common Stock, par value $.0001 |
P - Purchase | 90,000 | 236,770 | 61.32 | 10.00 | 900,000 | 2,367,700 | |
2019-03-07 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
J - Other | 2,908 | 4,908 | 145.40 | 85.97 | 250,001 | 421,941 | |
2019-03-07 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
J - Other | -2,908 | 55,005 | -5.02 | 85.97 | -250,001 | 4,728,780 | |
2019-02-14 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
P - Purchase | 2,000 | 2,000 | 89.99 | 179,980 | 179,980 | ||
2019-02-14 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
G - Gift | -5,100 | 57,913 | -8.09 | ||||
2019-02-05 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (right to buy) |
A - Award | 49,000 | 49,000 | |||||
2018-12-20 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -8,600 | 0 | -100.00 | ||||
2018-12-20 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 8,600 | 63,013 | 15.81 | 59.06 | 507,873 | 3,721,233 | |
2018-11-28 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -10,000 | 8,600 | -53.76 | ||||
2018-11-28 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 10,000 | 54,413 | 22.52 | 59.06 | 590,550 | 3,213,360 | |
2018-10-31 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (right to buy) |
M - Exercise | -44,000 | 0 | -100.00 | ||||
2018-10-31 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (right to buy) |
M - Exercise | -833 | 0 | -100.00 | ||||
2018-10-31 |
|
4 | KIN |
Kindred Biosciences, Inc.
Common Stock |
M - Exercise | 44,000 | 169,000 | 35.20 | 3.45 | 151,800 | 583,050 | |
2018-10-31 |
|
4 | KIN |
Kindred Biosciences, Inc.
Common Stock |
M - Exercise | 833 | 125,000 | 0.67 | 1.37 | 1,141 | 171,250 | |
2018-08-13 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
S - Sale | -12,000 | 44,413 | -21.27 | 92.32 | -1,107,888 | 4,100,386 | |
2018-07-26 |
|
4 | EYEN |
EYENOVIA, INC.
Stock Option (right to buy) |
A - Award | 4,465 | 4,465 | |||||
2018-07-26 |
|
4 | EYEN |
EYENOVIA, INC.
Common Stock, par value $.0001 |
A - Award | 4,033 | 146,770 | 2.83 | ||||
2018-06-27 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 16,500 | 50,000 | 49.25 | 4.48 | 73,920 | 224,000 | |
2018-06-26 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (Right to Buy) |
A - Award | 10,000 | 10,000 | |||||
2018-06-18 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -334 | 0 | -100.00 | ||||
2018-06-18 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 334 | 56,413 | 0.60 | ||||
2018-06-18 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Employee stock option (right to buy) |
A - Award | 15,931 | 15,931 | |||||
2018-06-15 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -375 | 375 | -50.00 | ||||
2018-06-15 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 375 | 56,079 | 0.67 | ||||
2018-06-15 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -300 | 600 | -33.33 | ||||
2018-06-15 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 300 | 55,704 | 0.54 | ||||
2018-06-15 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 13,266 | 13,266 | |||||
2018-06-15 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 1,454 | 1,454 | |||||
2018-06-13 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Stock Option |
A - Award | 20,000 | 20,000 | |||||
2018-06-13 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 3,606 | 475,324 | 0.76 | 2.04 | 7,356 | 969,661 | |
2018-06-13 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 500 | 471,718 | 0.11 | 2.04 | 1,020 | 962,305 | |
2018-06-13 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 4,980 | 471,218 | 1.07 | 2.05 | 10,209 | 965,997 | |
2018-06-11 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 14,803 | 466,238 | 3.28 | 2.04 | 30,257 | 952,990 | |
2018-06-11 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 4,611 | 451,435 | 1.03 | 2.00 | 9,234 | 903,999 | |
2018-06-07 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 1,200 | 446,824 | 0.27 | 2.05 | 2,460 | 915,989 | |
2018-06-04 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 1,300 | 445,624 | 0.29 | 2.05 | 2,665 | 913,529 | |
2018-06-04 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 500 | 444,324 | 0.11 | 2.05 | 1,025 | 910,864 | |
2018-05-29 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 500 | 443,824 | 0.11 | 2.01 | 1,005 | 892,086 | |
2018-05-29 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 5,000 | 443,324 | 1.14 | 2.05 | 10,250 | 908,814 | |
2018-05-22 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 5,000 | 438,324 | 1.15 | 1.94 | 9,720 | 852,102 | |
2018-05-22 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 25,000 | 433,324 | 6.12 | 1.95 | 48,750 | 844,982 | |
2018-05-21 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
S - Sale | -15,000 | 108,167 | -12.18 | 4.81 | -72,142 | 520,229 | |
2018-05-21 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
S - Sale | -30,000 | 123,167 | -19.59 | 4.80 | -143,931 | 590,918 | |
2018-05-21 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 25,000 | 408,324 | 6.52 | 1.90 | 47,500 | 775,816 | |
2018-05-17 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
S - Sale | -30,000 | 153,167 | -16.38 | 4.79 | -143,808 | 734,221 | |
2018-05-16 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
S - Sale | -30,000 | 183,167 | -14.07 | 4.69 | -140,808 | 859,713 | |
2018-05-15 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
S - Sale | -22,553 | 213,167 | -9.57 | 4.67 | -105,232 | 994,637 | |
2018-05-15 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
S - Sale | -22,857 | 235,720 | -8.84 | 4.63 | -105,766 | 1,090,747 | |
2018-05-15 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
S - Sale | -7,143 | 258,577 | -2.69 | 4.57 | -32,614 | 1,180,637 | |
2018-05-11 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
S - Sale | -2,815 | 265,720 | -1.05 | 4.60 | -12,949 | 1,222,312 | |
2018-04-24 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (Right to Buy) |
A - Award | 44,603 | 44,603 | |||||
2018-04-11 | 3 | KIN |
Kindred Biosciences, Inc.
Common Stock |
248,334 | ||||||||
2018-04-11 | 3 | KIN |
Kindred Biosciences, Inc.
Common Stock |
248,334 | ||||||||
2018-04-11 | 3 | KIN |
Kindred Biosciences, Inc.
Common Stock |
248,334 | ||||||||
2018-03-09 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
G - Gift | 10,000 | 33,500 | 42.55 | ||||
2018-03-09 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
G - Gift | -10,000 | 0 | -100.00 | ||||
2018-03-09 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Restricted Stock Units |
M - Exercise | -750 | 0 | -100.00 | ||||
2018-03-09 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
M - Exercise | 750 | 64,572 | 1.18 | ||||
2018-03-09 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Restricted Stock Units |
M - Exercise | -750 | 0 | -100.00 | ||||
2018-03-09 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
M - Exercise | 750 | 63,822 | 1.19 | ||||
2018-03-09 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Restricted Stock Units |
M - Exercise | -600 | 0 | -100.00 | ||||
2018-03-09 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
M - Exercise | 600 | 26,648 | 2.30 | ||||
2018-02-26 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
S - Sale | -13,370 | 55,404 | -19.44 | 94.49 | -1,263,298 | 5,234,985 | |
2018-02-26 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
G - Gift | -2,250 | 324 | -87.41 | ||||
2018-02-26 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
G - Gift | -2,250 | 324 | -87.41 | ||||
2018-02-07 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 8,689 | 704,352 | 1.25 | 1.73 | 15,000 | 1,215,923 | |
2018-01-24 | 3 | EYEN |
EYENOVIA, INC.
Common Stock, par value $.0001 |
285,474 | ||||||||
2018-01-24 | 3 | EYEN |
EYENOVIA, INC.
Common Stock, par value $.0001 |
285,474 | ||||||||
2017-12-22 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
S - Sale | -5,000 | 23,500 | -17.54 | 3.46 | -17,300 | 81,310 | |
2017-12-22 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
S - Sale | -8,965 | 28,500 | -23.93 | 3.44 | -30,840 | 98,040 | |
2017-12-22 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
S - Sale | -6,035 | 37,465 | -13.87 | 3.51 | -21,183 | 131,502 | |
2017-12-22 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
S - Sale | -10,000 | 43,500 | -18.69 | 3.57 | -35,700 | 155,295 | |
2017-12-22 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
S - Sale | -5,000 | 53,500 | -8.55 | 3.55 | -17,750 | 189,925 | |
2017-12-22 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
S - Sale | -1,967 | 55,467 | -3.42 | 3.58 | -7,042 | 198,572 | |
2017-11-01 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -13,600 | 0 | -100.00 | ||||
2017-11-01 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 13,600 | 71,024 | 23.68 | 31.80 | 432,412 | 2,258,208 | |
2017-10-04 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 28,846 | 1,873,174 | 1.56 | 0.52 | 15,000 | 974,050 | |
2017-08-31 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
S - Sale | -12,000 | 57,424 | -17.29 | 121.24 | -1,454,880 | 6,962,086 | |
2017-08-14 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
S - Sale | -18,506 | 69,424 | -21.05 | 130.52 | -2,415,403 | 9,061,220 | |
2017-07-17 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 24,590 | 1,844,328 | 1.35 | 0.61 | 15,000 | 1,125,040 | |
2017-07-05 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -734 | 0 | -100.00 | ||||
2017-07-05 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 734 | 87,930 | 0.84 | ||||
2017-06-30 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
S - Sale | -6,105 | 5,895 | -50.88 | 4.28 | -26,117 | 25,219 | |
2017-06-29 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
A - Award | 6,341 | 6,341 | |||||
2017-06-29 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
A - Award | 21,000 | 21,000 | |||||
2017-06-21 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Stock Option |
A - Award | 20,000 | 20,000 | |||||
2017-06-20 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -333 | 334 | -49.93 | ||||
2017-06-20 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 333 | 87,196 | 0.38 | ||||
2017-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -375 | 750 | -33.33 | ||||
2017-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 375 | 86,863 | 0.43 | ||||
2017-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 900 | 900 | |||||
2017-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 10,500 | 10,500 | |||||
2017-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
G - Gift | -3,570 | 86,488 | -3.96 | ||||
2017-05-09 |
|
4 | CAPN |
Capnia, Inc.
Employee stock option (right to buy) |
A - Award | 45,139 | 45,139 | |||||
2017-04-13 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
A - Award | 23,809 | 1,819,738 | 1.33 | 0.63 | 15,000 | 1,146,435 | |
2017-04-13 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
A - Award | 16,667 | 1,795,929 | 0.94 | 0.90 | 15,000 | 1,616,336 | |
2017-01-31 |
|
5 | CELG |
CELGENE CORP /DE/
Common Stock |
G - Gift | -4,125 | 90,058 | -4.38 | ||||
2016-12-29 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
S - Sale | -20,291 | 268,535 | -7.03 | 4.52 | -91,634 | 1,212,704 | |
2016-12-29 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
S - Sale | -4,000 | 288,826 | -1.37 | 4.67 | -18,683 | 1,349,020 | |
2016-12-29 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
S - Sale | -3,636 | 292,826 | -1.23 | 4.65 | -16,907 | 1,361,641 | |
2016-12-29 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
S - Sale | X | -72,073 | 296,462 | -19.56 | 4.68 | -337,143 | 1,386,790 |
2016-11-28 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 120,000 | 120,000 | 0.40 | 48,600 | 48,600 | ||
2016-10-31 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock Purchase Warrant |
P - Purchase | 100,000 | 100,000 | |||||
2016-10-31 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 100,000 | 630,724 | 18.84 | ||||
2016-10-11 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
A - Award | 15,625 | 1,779,262 | 0.89 | ||||
2016-09-26 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
S - Sale | -15,000 | 90,058 | -14.28 | 109.42 | -1,641,300 | 9,854,146 | |
2016-09-14 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 100,000 | 530,724 | 23.22 | 0.79 | 79,180 | 420,227 | |
2016-08-19 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 25,000 | 1,763,637 | 1.44 | 0.99 | 24,750 | 1,746,001 | |
2016-08-19 |
|
4/A | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 5,637 | 1,688,637 | 0.33 | 1.20 | 6,764 | 2,026,364 | |
2016-08-19 |
|
4/A | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 43,169 | 1,683,000 | 2.63 | 1.18 | 50,875 | 1,983,416 | |
2016-08-19 |
|
4/A | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 50,000 | 1,738,637 | 2.96 | 1.24 | 62,000 | 2,155,910 | |
2016-07-05 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -733 | 734 | -49.97 | ||||
2016-07-05 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 733 | 105,058 | 0.70 | ||||
2016-06-28 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
A - Award | 9,634 | 9,634 | |||||
2016-06-28 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
A - Award | 9,000 | 9,000 | |||||
2016-06-28 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 50,000 | 381,440 | 15.09 | 3.70 | 184,845 | 1,410,146 | |
2016-06-21 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 50,000 | 430,724 | 13.13 | 2.00 | 100,000 | 861,448 | |
2016-06-17 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -333 | 667 | -33.30 | ||||
2016-06-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 333 | 104,325 | 0.32 | ||||
2016-06-17 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 1,125 | 1,125 | |||||
2016-06-17 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 11,000 | 11,000 | |||||
2016-06-13 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -2,068 | 0 | -100.00 | ||||
2016-06-13 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 2,068 | 103,992 | 2.03 | ||||
2016-06-10 |
|
4 | CAPN |
Capnia, Inc.
Employee stock option (right to buy) |
A - Award | 27,083 | 27,083 | |||||
2016-06-09 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 50,000 | 1,918,637 | 2.68 | 1.24 | 62,000 | 2,379,110 | |
2016-05-31 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Restricted Stock Unit |
A - Award | 7,500 | 7,500 | |||||
2016-05-23 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 5,637 | 1,868,637 | 0.30 | 1.20 | 6,764 | 2,242,364 | |
2016-05-23 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 43,169 | 1,863,000 | 2.37 | 1.18 | 50,875 | 2,195,546 | |
2016-05-16 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 10,000 | 331,440 | 3.11 | 4.53 | 45,328 | 1,502,351 | |
2016-05-12 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 31,042 | 380,724 | 8.88 | 2.30 | 71,356 | 875,170 | |
2016-05-11 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 8,210 | 349,682 | 2.40 | 2.24 | 18,399 | 783,672 | |
2016-05-11 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 24,200 | 321,440 | 8.14 | 4.85 | 117,365 | 1,558,920 | |
2016-05-11 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 800 | 297,240 | 0.27 | 4.76 | 3,804 | 1,413,376 | |
2016-05-05 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -1,761 | 15,845 | -10.00 | ||||
2016-05-05 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 1,761 | 296,440 | 0.60 | 5.05 | 8,893 | 1,497,022 | |
2016-04-28 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -5,000 | 13,600 | -26.88 | ||||
2016-04-28 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 5,000 | 101,924 | 5.16 | 31.80 | 158,975 | 3,240,674 | |
2016-04-05 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -1,760 | 17,606 | -9.09 | ||||
2016-04-05 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 1,760 | 294,679 | 0.60 | 5.05 | 8,888 | 1,488,129 | |
2016-03-17 |
|
4 | KIN |
Kindred Biosciences, Inc.
Common Stock |
P - Purchase | 30,000 | 99,583 | 43.11 | 3.55 | 106,500 | 353,520 | |
2016-03-17 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 75,000 | 341,472 | 28.15 | 2.29 | 171,712 | 781,800 | |
2016-03-16 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 5,000 | 292,919 | 1.74 | 4.78 | 23,898 | 1,400,036 | |
2016-03-16 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 20,000 | 287,919 | 7.46 | 5.13 | 102,628 | 1,477,428 | |
2016-03-09 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -1,761 | 19,366 | -8.34 | ||||
2016-03-09 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 1,761 | 267,919 | 0.66 | 5.05 | 8,893 | 1,352,991 | |
2016-02-10 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Restricted Stock Unit |
A - Award | 7,500 | 7,500 | |||||
2016-02-09 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -1,760 | 21,127 | -7.69 | ||||
2016-02-09 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 1,760 | 266,158 | 0.67 | 5.05 | 8,888 | 1,344,098 | |
2016-02-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -18,600 | 0 | -100.00 | ||||
2016-02-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 18,600 | 101,049 | 22.56 | 29.00 | 539,400 | 2,930,421 | |
2016-01-14 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -1,761 | 22,887 | -7.14 | ||||
2016-01-14 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 1,761 | 264,398 | 0.67 | 5.05 | 8,893 | 1,335,210 | |
2016-01-12 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (right to buy) |
A - Award | 44,000 | 44,000 | |||||
2015-12-30 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 125,000 | 262,637 | 90.82 | 7.09 | 886,612 | 1,862,858 | |
2015-12-30 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
S - Sale | -40,000 | 82,449 | -32.67 | 119.36 | -4,774,400 | 9,841,113 | |
2015-12-11 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -1,760 | 24,648 | -6.66 | ||||
2015-12-11 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 1,760 | 137,637 | 1.30 | 5.05 | 8,888 | 695,067 | |
2015-11-18 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 50,000 | 1,639,831 | 3.14 | 1.77 | 88,500 | 2,902,501 | |
2015-11-17 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | -125,000 | 86,032 | -59.23 | 17.63 | -2,203,162 | 1,516,340 | |
2015-11-10 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -1,761 | 26,408 | -6.25 | ||||
2015-11-10 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 1,761 | 135,877 | 1.31 | 5.05 | 8,893 | 686,179 | |
2015-10-07 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -1,761 | 28,169 | -5.88 | ||||
2015-10-07 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 1,761 | 134,116 | 1.33 | 5.05 | 8,893 | 677,286 | |
2015-09-14 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 15,000 | 1,589,831 | 0.95 | 2.28 | 34,200 | 3,624,815 | |
2015-09-08 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -832 | 8,319 | -9.09 | ||||
2015-09-08 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -1,760 | 29,930 | -5.55 | ||||
2015-09-08 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 832 | 132,355 | 0.63 | 45.15 | 37,565 | 5,975,828 | |
2015-09-08 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 1,760 | 131,523 | 1.36 | 5.05 | 8,888 | 664,191 | |
2015-08-27 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 10,000 | 260,472 | 3.99 | 6.05 | 60,500 | 1,575,856 | |
2015-08-26 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 1,468 | 250,472 | 0.59 | 6.40 | 9,395 | 1,603,021 | |
2015-08-25 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 16,228 | 1,553,999 | 1.06 | 1.91 | 30,995 | 2,968,138 | |
2015-08-25 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 2,532 | 249,004 | 1.03 | 6.20 | 15,698 | 1,543,825 | |
2015-08-20 |
|
4 | CAPN |
Capnia, Inc.
Warrant (right to buy) |
J - Other | -50,000 | 0 | -100.00 | ||||
2015-08-20 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
J - Other | 210,251 | 1,477,771 | 16.59 | ||||
2015-08-20 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 6,000 | 246,472 | 2.50 | 6.64 | 39,867 | 1,637,683 | |
2015-08-20 |
|
4/A | CAPN |
Capnia, Inc.
Common Stock |
J - Other | 210,251 | 1,537,771 | 15.84 | ||||
2015-08-17 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 15,000 | 240,472 | 6.65 | 6.93 | 104,018 | 1,667,553 | |
2015-08-13 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 10,000 | 1,327,520 | 0.76 | 1.64 | 16,440 | 2,182,443 | |
2015-08-12 |
|
4 | CAPN |
Capnia, Inc.
Warrant (right to buy) |
J - Other | -205,188 | 0 | -100.00 | ||||
2015-08-12 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 50,000 | 1,317,520 | 3.94 | 1.77 | 88,500 | 2,332,010 | |
2015-08-12 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
J - Other | 786,645 | 1,267,520 | 163.59 | ||||
2015-08-07 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -832 | 9,151 | -8.33 | ||||
2015-08-07 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -129 | 0 | -100.00 | ||||
2015-08-07 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -750 | 0 | -100.00 | ||||
2015-08-07 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -3,521 | 31,690 | -10.00 | ||||
2015-08-07 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 832 | 129,763 | 0.65 | 45.15 | 37,565 | 5,858,799 | |
2015-08-07 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 129 | 128,931 | 0.10 | 23.26 | 3,001 | 2,998,935 | |
2015-08-07 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 750 | 128,802 | 0.59 | 23.26 | 17,445 | 2,995,935 | |
2015-08-07 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 3,521 | 128,052 | 2.83 | 5.05 | 17,781 | 646,663 | |
2015-08-04 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
S - Sale | -19,442 | 122,449 | -13.70 | 131.73 | -2,561,139 | 16,130,488 | |
2015-07-17 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 25,000 | 225,472 | 12.47 | 7.50 | 187,500 | 1,691,040 | |
2015-07-06 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -733 | 1,467 | -33.32 | ||||
2015-07-06 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 733 | 141,891 | 0.52 | ||||
2015-06-26 |
|
4 | CAPN |
Capnia, Inc.
Employee stock option (right to buy) |
M - Exercise | -54,999 | 0 | -100.00 | ||||
2015-06-26 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
M - Exercise | 54,999 | 480,875 | 12.91 | 3.48 | 191,397 | 1,673,445 | |
2015-06-24 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
A - Award | 9,983 | 9,983 | |||||
2015-06-19 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 1,000 | 1,000 | |||||
2015-06-19 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 10,000 | 10,000 | |||||
2015-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -2,068 | 0 | -100.00 | ||||
2015-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 2,068 | 141,158 | 1.49 | ||||
2015-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -2,066 | 2,068 | -49.98 | ||||
2015-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 2,066 | 139,090 | 1.51 | ||||
2015-06-11 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -258 | 129 | -66.67 | ||||
2015-06-11 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -1,500 | 750 | -66.67 | ||||
2015-06-11 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -3,521 | 35,211 | -9.09 | ||||
2015-06-11 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 258 | 124,531 | 0.21 | 23.26 | 6,001 | 2,896,591 | |
2015-06-11 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 1,500 | 124,273 | 1.22 | 23.26 | 34,890 | 2,890,590 | |
2015-06-11 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 3,521 | 122,773 | 2.95 | 5.05 | 17,781 | 620,004 | |
2015-06-08 |
|
4 | CAPN |
Capnia, Inc.
Employee stock option (right to buy) |
M - Exercise | -25,000 | 54,999 | -31.25 | ||||
2015-06-08 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
M - Exercise | 25,000 | 425,876 | 6.24 | 3.48 | 87,000 | 1,482,048 | |
2015-06-04 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (right to buy) |
M - Exercise | 8,750 | 11,250 | 350.00 | ||||
2015-06-04 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (right to buy) |
M - Exercise | 8,333 | 14,167 | 142.84 | ||||
2015-06-04 |
|
4 | KIN |
Kindred Biosciences, Inc.
Common Stock |
M - Exercise | 8,750 | 69,583 | 14.38 | 1.37 | 11,988 | 95,329 | |
2015-06-04 |
|
4 | KIN |
Kindred Biosciences, Inc.
Common STock |
M - Exercise | 8,333 | 60,833 | 15.87 | 0.32 | 2,667 | 19,467 | |
2015-05-21 |
|
4 | XNPT |
XENOPORT INC
Non-Employee Restricted Stock Unit |
M - Exercise | -5,000 | 0 | -100.00 | ||||
2015-05-21 |
|
4 | XNPT |
XENOPORT INC
Common Stock |
M - Exercise | 5,000 | 88,750 | 5.97 | ||||
2015-05-19 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | -50,000 | 211,032 | -19.15 | 18.09 | -904,630 | 3,818,118 | |
2015-05-19 |
|
4 | CAPN |
Capnia, Inc.
Employee Stock Option |
A - Award | 5,000 | 5,000 | |||||
2015-05-07 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Deferred Stock Units |
A - Award | 10,650 | 10,650 | |||||
2015-04-07 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -130 | 387 | -25.15 | ||||
2015-04-07 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -750 | 2,250 | -25.00 | ||||
2015-04-07 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -1,761 | 38,732 | -4.35 | ||||
2015-04-07 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 130 | 119,252 | 0.11 | 23.26 | 3,024 | 2,773,802 | |
2015-04-07 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 750 | 119,122 | 0.63 | 23.26 | 17,445 | 2,770,778 | |
2015-04-07 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 1,761 | 118,372 | 1.51 | 5.05 | 8,893 | 597,779 | |
2015-03-20 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -258 | 517 | -33.29 | ||||
2015-03-20 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -1,500 | 3,000 | -33.33 | ||||
2015-03-20 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -3,521 | 40,493 | -8.00 | ||||
2015-03-20 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 258 | 116,611 | 0.22 | 23.26 | 6,001 | 2,712,372 | |
2015-03-20 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 1,500 | 116,353 | 1.31 | 23.26 | 34,890 | 2,706,371 | |
2015-03-20 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 3,521 | 114,853 | 3.16 | 5.05 | 17,781 | 580,008 | |
2015-03-06 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 4,000 | 200,472 | 2.04 | 6.57 | 26,280 | 1,317,081 | |
2015-02-27 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Restricted Stock Unit |
A - Award | 6,000 | 6,000 | |||||
2015-02-27 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Stock Option |
A - Award | 5,000 | 5,000 | |||||
2015-02-09 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 30,000 | 196,472 | 18.02 | 5.85 | 175,500 | 1,149,361 | |
2015-02-04 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -7,666 | 0 | -100.00 | ||||
2015-02-04 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 7,666 | 137,024 | 5.93 | 27.69 | 212,272 | 3,794,195 | |
2015-01-28 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (right to buy) |
A - Award | 44,000 | 44,000 | |||||
2015-01-20 |
|
4 | CMRX |
CHIMERIX INC
Common Stock (Right to Buy) |
M - Exercise | -258 | 775 | -24.98 | ||||
2015-01-20 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -1,500 | 4,500 | -25.00 | ||||
2015-01-20 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -3,521 | 44,014 | -7.41 | ||||
2015-01-20 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 258 | 111,332 | 0.23 | 23.26 | 6,001 | 2,589,582 | |
2015-01-20 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 1,500 | 111,074 | 1.37 | 23.26 | 34,890 | 2,583,581 | |
2015-01-20 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 3,521 | 109,574 | 3.32 | 5.05 | 17,781 | 553,349 | |
2015-01-13 |
|
4 | CAPN |
Capnia, Inc.
Employee Stock Option |
A - Award | 5,000 | 5,000 | |||||
2014-12-19 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Series A common stock purchase warrant |
X - Other | -30,000 | 0 | -100.00 | ||||
2014-12-19 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
X - Other | 30,000 | 166,472 | 21.98 | 4.25 | 127,500 | 707,506 | |
2014-12-02 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | X | -10,000 | 261,032 | -3.69 | 12.96 | -129,618 | 3,383,445 |
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Series A Warrant to Purchase Common Stock |
P - Purchase | 253,846 | 597,232 | 73.92 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Series B Warrant to Purchase Common Stock |
P - Purchase | 253,846 | 597,232 | 73.92 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Series A Warrant to Purchase Common Stock |
P - Purchase | 44,770 | 89,540 | 100.00 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Series B Warrant to Purchase Common Stock |
P - Purchase | 44,770 | 89,540 | 100.00 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Warrant to Purchase Common Stock |
J - Other | 21,928 | 43,893 | 99.83 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Warrant to Purchase Common Stock |
J - Other | 8,275 | 21,965 | 60.45 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Warrant to Purchase Common Stock |
J - Other | 13,690 | 13,690 | |||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Series C Preferred Stock |
C - Conversion | -10,416 | 0 | -100.00 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Series C Preferred Stock |
C - Conversion | -10,416 | 0 | -100.00 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Series C Preferred Stock |
C - Conversion | -48,885 | 20,832 | -70.12 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
2014 Convertible Promissory Notes |
S - Sale | -203,705 | 0 | -100.00 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
2010/2012 Convertible Promissory Notes |
S - Sale | -555,250 | 0 | -100.00 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
2010/2012 Convertible Promissory Notes |
S - Sale | -260,471 | 0 | -100.00 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
2010/2012 Convertible Promissory Notes |
S - Sale | -471,192 | 0 | -100.00 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 253,846 | 632,720 | 67.00 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 44,770 | 378,874 | 13.40 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 114,072 | 334,104 | 51.84 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 53,512 | 220,032 | 32.14 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 96,803 | 166,520 | 138.85 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
C - Conversion | 10,416 | 69,717 | 17.56 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
C - Conversion | 10,416 | 69,717 | 17.56 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
C - Conversion | 48,885 | 48,885 | |||||
2014-11-14 |
|
4 | CAPN |
Capnia, Inc.
Employee Stock Option |
A - Award | 7,000 | 56,772 | 14.06 | ||||
2014-11-14 |
|
4 | CAPN |
Capnia, Inc.
Employee Stock Option |
A - Award | 49,772 | 56,772 | 711.03 | ||||
2014-11-12 | 3 | CAPN |
Capnia, Inc.
No securities beneficially owned |
0 | ||||||||
2014-11-06 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 10,000 | 106,053 | 10.41 | 29.00 | 290,000 | 3,075,537 | |
2014-11-06 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -517 | 1,033 | -33.35 | ||||
2014-11-06 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -3,000 | 6,000 | -33.33 | ||||
2014-11-06 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -5,282 | 47,535 | -10.00 | ||||
2014-11-06 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 517 | 96,053 | 0.54 | 23.26 | 12,025 | 2,234,193 | |
2014-11-06 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 3,000 | 95,536 | 3.24 | 23.26 | 69,780 | 2,222,167 | |
2014-11-06 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 5,282 | 92,536 | 6.05 | 5.05 | 26,674 | 467,307 | |
2014-11-04 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | X | -10,000 | 271,032 | -3.56 | 13.30 | -132,998 | 3,604,671 |
2014-11-03 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
A - Award | 13,177 | 281,032 | 4.92 | ||||
2014-10-31 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Stock Option |
A - Award | 5,000 | 5,000 | |||||
2014-10-29 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
S - Sale | -100,000 | 129,358 | -43.60 | 102.85 | -10,284,630 | 13,303,992 | |
2014-10-09 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | X | -10,000 | 267,855 | -3.60 | 12.06 | -120,600 | 3,230,331 |
2014-09-29 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Series A common stock purchase warrant |
X - Other | -10,000 | 30,000 | -25.00 | ||||
2014-09-29 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
X - Other | 10,000 | 136,472 | 7.91 | 4.25 | 42,500 | 580,006 | |
2014-09-08 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 10,000 | 87,254 | 12.94 | 23.19 | 231,872 | 2,023,176 | |
2014-09-03 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | X | -10,000 | 277,855 | -3.47 | 12.60 | -125,992 | 3,500,751 |
2014-09-03 |
|
4 | Kin |
Kindred Biosciences, Inc.
Common Stock |
P - Purchase | 10,000 | 52,500 | 23.53 | 10.55 | 105,493 | 553,838 | |
2014-08-27 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Series A common stock purchase warrant |
X - Other | -7,059 | 40,000 | -15.00 | ||||
2014-08-27 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
X - Other | 7,059 | 126,472 | 5.91 | 4.25 | 30,001 | 537,506 | |
2014-08-27 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -8,803 | 52,817 | -14.29 | ||||
2014-08-27 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 8,803 | 77,254 | 12.86 | 5.05 | 44,455 | 390,133 | |
2014-08-06 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (right to buy) |
M - Exercise | -2,500 | 22,500 | -10.00 | ||||
2014-08-06 |
|
4 | KIN |
Kindred Biosciences, Inc.
Common Stock |
M - Exercise | 2,500 | 42,500 | 6.25 | 0.32 | 800 | 13,600 | |
2014-08-05 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | X | -10,000 | 287,855 | -3.36 | 12.58 | -125,817 | 3,621,705 |
2014-07-28 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -5,000 | 7,666 | -39.48 | ||||
2014-07-28 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 5,000 | 229,358 | 2.23 | 27.69 | 138,450 | 6,350,923 | |
2014-07-28 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
G - Gift | -196 | 2,574 | -7.08 | ||||
2014-07-28 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
G - Gift | -196 | 2,574 | -7.08 | ||||
2014-07-28 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
G - Gift | -2,210 | 2,770 | -44.38 | ||||
2014-07-28 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
G - Gift | -2,210 | 2,770 | -44.38 | ||||
2014-07-28 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
G - Gift | -1,020 | 4,980 | -17.00 | ||||
2014-07-28 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
G - Gift | -1,020 | 4,980 | -17.00 | ||||
2014-07-02 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | X | -10,000 | 297,855 | -3.25 | 12.95 | -129,468 | 3,856,269 |
2014-07-02 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 2,200 | 2,200 | |||||
2014-07-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 20,700 | 20,700 | |||||
2014-06-24 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
A - Award | 1,550 | 1,550 | |||||
2014-06-24 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
A - Award | 9,000 | 9,000 | |||||
2014-06-19 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Stock Option |
A - Award | 5,000 | 5,000 | |||||
2014-06-17 |
|
4 | XNPT |
XENOPORT INC
Non-employee director stock unit |
A - Award | 5,000 | 5,000 | |||||
2014-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 2,055 | 113,892 | 1.84 | ||||
2014-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -2,055 | 0 | -100.00 | ||||
2014-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -3,100 | 0 | -100.00 | ||||
2014-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 3,100 | 111,837 | 2.85 | ||||
2014-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -1,033 | 1,034 | -49.98 | ||||
2014-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 1,033 | 108,737 | 0.96 | ||||
2014-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -1,033 | 2,067 | -33.32 | ||||
2014-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 1,033 | 107,704 | 0.97 | ||||
2014-06-11 |
|
4 | XNPT |
XENOPORT INC
Non-employee director stock option |
A - Award | 15,000 | 15,000 | |||||
2014-06-03 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | X | -10,000 | 307,855 | -3.15 | 12.88 | -128,790 | 3,964,865 |
2014-05-28 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 10,000 | 68,451 | 17.11 | 14.22 | 142,200 | 973,373 | |
2014-05-27 |
|
4 | XNPT |
XENOPORT INC
Common Stock |
P - Purchase | 30,000 | 83,750 | 55.81 | 3.73 | 111,978 | 312,605 | |
2014-05-23 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (right to buy) |
M - Exercise | -2,500 | 25,000 | -9.09 | ||||
2014-05-23 |
|
4 | KIN |
Kindred Biosciences, Inc.
Common Stock |
M - Exercise | 2,500 | 40,000 | 6.67 | 0.32 | 800 | 12,800 | |
2014-05-16 |
|
4 | XNPT |
XENOPORT INC
Non-employee direct stock unit |
M - Exercise | -5,000 | 0 | -100.00 | ||||
2014-05-16 |
|
4 | XNPT |
XENOPORT INC
Common Stock |
M - Exercise | 5,000 | 53,750 | 10.26 | ||||
2014-05-02 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | X | -10,000 | 317,855 | -3.05 | 12.58 | -125,836 | 3,999,760 |
2014-04-08 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -6,000 | 6,333 | -48.65 | ||||
2014-04-08 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 6,000 | 106,671 | 5.96 | 55.38 | 332,280 | 5,907,440 | |
2014-04-02 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | X | -10,000 | 327,855 | -2.96 | 13.55 | -135,527 | 4,443,320 |
2014-04-01 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -7,047 | 61,620 | -10.26 | ||||
2014-04-01 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 7,047 | 58,451 | 13.71 | 5.05 | 35,587 | 295,178 | |
2014-03-05 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | X | -10,000 | 337,855 | -2.87 | 12.98 | -129,755 | 4,383,838 |
2014-02-26 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Stock Option |
A - Award | 5,500 | 5,500 | |||||
2014-02-07 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | -17,104 | 347,855 | -4.69 | 12.80 | -218,935 | 4,452,614 | |
2014-02-06 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -6,875 | 0 | -100.00 | ||||
2014-02-06 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -4,625 | 0 | -100.00 | ||||
2014-02-06 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -2,000 | 0 | -100.00 | ||||
2014-02-06 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
S - Sale | -13,500 | 100,671 | -11.82 | 151.87 | -2,050,284 | 15,289,197 | |
2014-02-06 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 6,875 | 114,171 | 6.41 | 60.02 | 412,638 | 6,852,543 | |
2014-02-06 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 4,625 | 107,296 | 4.50 | 67.75 | 313,344 | 7,269,304 | |
2014-02-06 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 2,000 | 102,671 | 1.99 | 59.89 | 119,780 | 6,148,966 | |
2014-02-06 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -7,000 | 6,875 | -50.45 | ||||
2014-02-06 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 7,000 | 100,671 | 7.47 | 60.02 | 420,140 | 6,042,273 | |
2014-02-05 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (right to buy) |
M - Exercise | -12,500 | 27,500 | -31.25 | ||||
2014-02-05 |
|
4 | KIN |
Kindred Biosciences, Inc.
Common Stock |
M - Exercise | 12,500 | 37,500 | 50.00 | 0.32 | 4,000 | 12,000 | |
2014-02-05 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (right to buy) |
A - Award | 37,000 | 37,000 | |||||
2014-02-04 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | X | -10,000 | 364,959 | -2.67 | 13.19 | -131,884 | 4,813,225 |
2014-01-09 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -2,000 | 2,000 | -50.00 | ||||
2014-01-09 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 2,000 | 93,671 | 2.18 | 59.89 | 119,780 | 5,609,956 | |
2014-01-08 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | X | -10,000 | 374,959 | -2.60 | 12.50 | -125,000 | 4,686,988 |
2013-12-30 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | X | -10,000 | 384,959 | -2.53 | 12.06 | -120,600 | 4,642,606 |
2013-12-13 |
|
4 | KIN |
Kindred Biosciences, Inc.
Common Stock |
P - Purchase | 25,000 | 25,000 | 7.00 | 175,000 | 175,000 | ||
2013-12-13 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 5,000 | 51,404 | 10.77 | 13.90 | 69,500 | 714,516 | |
2013-11-25 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 8,000 | 46,404 | 20.83 | 15.20 | 121,600 | 705,341 | |
2013-11-20 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -15,840 | 68,667 | -18.74 | ||||
2013-11-20 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 15,840 | 38,404 | 70.20 | 5.05 | 79,992 | 193,940 | |
2013-11-20 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 7,500 | 22,564 | 49.79 | 15.25 | 114,375 | 344,101 | |
2013-11-12 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | -20,445 | 0 | -100.00 | 11.73 | -239,857 | ||
2013-11-12 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | -115,200 | 394,959 | -22.58 | 11.73 | -1,351,503 | 4,633,580 | |
2013-10-28 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -6,000 | 4,000 | -60.00 | ||||
2013-10-28 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 6,000 | 91,671 | 7.00 | 59.89 | 359,340 | 5,490,176 | |
2013-09-30 |
|
4 | XNPT |
XENOPORT INC
Non-employee director stock option |
M - Exercise | -18,750 | 11,250 | -62.50 | ||||
2013-09-30 |
|
4 | XNPT |
XENOPORT INC
Common stock |
M - Exercise | 18,750 | 48,750 | 62.50 | 5.79 | 108,562 | 282,262 | |
2013-09-03 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 64 | 15,064 | 0.43 | 15.75 | 1,008 | 237,258 | |
2013-09-03 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 786 | 15,000 | 5.53 | 15.80 | 12,419 | 237,000 | |
2013-09-03 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 1,714 | 14,214 | 13.71 | 15.80 | 27,081 | 224,581 | |
2013-09-03 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 2,500 | 12,500 | 25.00 | 15.85 | 39,625 | 198,125 | |
2013-08-27 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 2,000 | 10,000 | 25.00 | 16.80 | 33,600 | 168,000 | |
2013-08-27 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 2,000 | 8,000 | 33.33 | 17.30 | 34,600 | 138,400 | |
2013-08-27 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 1,960 | 6,000 | 48.51 | 17.50 | 34,300 | 105,000 | |
2013-08-20 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 40 | 4,040 | 1.00 | 17.50 | 700 | 70,700 | |
2013-08-20 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 2,000 | 4,000 | 100.00 | 17.50 | 35,000 | 70,000 | |
2013-08-20 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 2,000 | 2,000 | 17.45 | 34,900 | 34,900 | ||
2013-08-15 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -4,625 | 0 | -100.00 | ||||
2013-08-15 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 4,625 | 85,671 | 5.71 | 54.35 | 251,369 | 4,656,219 | |
2013-08-15 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Series A common stock purchase warrant |
P - Purchase | 47,059 | 47,059 | |||||
2013-08-15 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 47,059 | 119,713 | 64.77 | ||||
2013-06-17 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -1,033 | 2,067 | -33.32 | ||||
2013-06-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 1,033 | 81,046 | 1.29 | ||||
2013-06-14 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 3,100 | 3,100 | |||||
2013-06-14 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 9,300 | 9,300 | |||||
2013-06-07 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -15,000 | 10,000 | -60.00 | ||||
2013-06-07 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 15,000 | 80,013 | 23.07 | 59.89 | 898,350 | 4,791,979 | |
2013-05-30 |
|
4 | VVUS |
VIVUS INC
Common Stock |
P - Purchase | 15,000 | 81,125 | 22.68 | 14.68 | 220,206 | 1,190,947 | |
2013-05-30 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
P - Purchase | 400 | 65,013 | 0.62 | 123.73 | 49,493 | 8,044,189 | |
2013-05-30 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
P - Purchase | 600 | 64,613 | 0.94 | 123.72 | 74,232 | 7,993,920 | |
2013-05-23 |
|
4 | XNPT |
XENOPORT INC
Common Stock |
P - Purchase | 20,000 | 30,000 | 200.00 | 5.49 | 109,800 | 164,700 | |
2013-05-16 |
|
4 | XNPT |
XENOPORT INC
Non-employee director stock unit |
A - Award | 5,000 | 5,000 | |||||
2013-05-16 |
|
4 | XNPT |
XENOPORT INC
Non-employee director stock option |
A - Award | 15,000 | 15,000 | |||||
2013-05-08 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Phantom Stock |
A - Award | 22,756 | 130,098 | 21.20 | ||||
2013-05-08 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
P - Purchase | 30,000 | 509,304 | 6.26 | 7.76 | 232,800 | 3,952,199 | |
2013-04-29 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Warrants |
C - Conversion | -166,667 | 216,667 | -43.48 | ||||
2013-04-29 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock |
C - Conversion | 166,667 | 1,447,079 | 13.02 | 0.40 | 66,667 | 578,832 | |
2013-02-19 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Stock Option |
A - Award | 210,000 | 0 | -100.00 | ||||
2013-01-29 |
|
4 | VVUS |
VIVUS INC
Common Stock |
A - Award | 21,125 | 66,125 | 46.94 | ||||
2013-01-14 | 3 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, Par Value $0.001 |
1,280,412 | ||||||||
2012-08-21 |
|
4 | VVUS |
VIVUS INC
Common Stock |
P - Purchase | 5,000 | 45,000 | 12.50 | 20.75 | 103,750 | 933,750 | |
2012-08-13 |
|
4 | VVUS |
VIVUS INC
Common Stock |
P - Purchase | 5,000 | 40,000 | 14.29 | 21.50 | 107,500 | 860,000 | |
2012-08-13 |
|
4 | VVUS |
VIVUS INC
Common Stock |
P - Purchase | 15,000 | 35,000 | 75.00 | 21.83 | 327,399 | 763,931 | |
2012-08-09 |
|
4 | XNPT |
XENOPORT INC
Common Stock |
P - Purchase | 10,000 | 10,000 | 8.50 | 84,983 | 84,983 | ||
2012-08-08 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
P - Purchase | 32,000 | 479,304 | 7.15 | 5.29 | 169,280 | 2,535,518 | |
2012-06-19 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -685 | 0 | -100.00 | ||||
2012-06-19 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 685 | 64,013 | 1.08 | ||||
2012-06-18 |
|
4 | XNPT |
XENOPORT INC
Non-employee director stock option |
A - Award | 30,000 | 30,000 | |||||
2012-06-15 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 3,100 | 3,100 | |||||
2012-06-15 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 9,300 | 9,300 | |||||
2012-06-07 |
|
4 | MAXY |
MAXYGEN INC
Common Stock |
A - Award | 10,000 | 62,964 | 18.88 | ||||
2012-05-10 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Phantom Stock |
A - Award | 24,116 | 107,342 | 28.98 | ||||
2012-04-30 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -12,333 | 0 | -100.00 | ||||
2012-04-30 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -4,625 | 0 | -100.00 | ||||
2012-04-30 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 12,333 | 63,328 | 24.18 | 44.94 | 554,245 | 2,845,960 | |
2012-04-30 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 4,625 | 50,995 | 9.97 | 49.93 | 230,926 | 2,546,180 | |
2012-04-27 |
|
4 | VVUS |
VIVUS INC
Common Stock |
A - Award | 20,000 | 20,000 | |||||
2012-02-27 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
P - Purchase | 10,000 | 447,304 | 2.29 | 5.91 | 59,100 | 2,643,567 | |
2012-02-23 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
P - Purchase | 10,000 | 437,304 | 2.34 | 5.93 | 59,300 | 2,593,213 | |
2012-02-22 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
P - Purchase | 20,000 | 427,304 | 4.91 | 6.12 | 122,400 | 2,615,100 | |
2011-02-09 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
P - Purchase | 50,000 | 131,004 | 61.73 | 6.94 | 346,990 | 909,142 | |
2009-05-07 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Phantom Stock |
A - Award | 14,501 | 42,521 | 51.75 | ||||
2007-08-23 | 3 | CELG |
CELGENE CORP /DE/
Common Stock |
10,000 |